ACADIA Pharmaceuticals Inc.
ACAD
$15.35
-$0.77-4.78%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 338.71% | -1.87% | 101.69% | -63.85% | 170.27% |
| Total Depreciation and Amortization | 102.88% | -0.04% | -53.49% | 237.69% | -4.99% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -693.08% | 70.54% | 5.92% | -20.19% | 7.90% |
| Change in Net Operating Assets | 574.39% | 118.21% | -313.51% | -127.49% | 305.67% |
| Cash from Operations | -36.15% | 152.85% | -13.98% | -65.95% | 244.84% |
| Capital Expenditure | -547.14% | -- | -- | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 70.98% | -46.62% | -300.26% | -3,945.82% | -101.02% |
| Cash from Investing | 248.14% | -46.74% | -300.26% | -3,945.82% | -101.02% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 634.70% | -92.48% | 241.80% | -80.81% | -57.38% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 634.70% | -92.48% | 241.80% | -80.81% | -57.38% |
| Foreign Exchange rate Adjustments | -42.86% | -1,500.00% | -40.00% | 141.67% | -200.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 966.16% | 31.24% | -271.62% | -82.22% | 847.76% |
